Indian generic drug manufacturers play a significant role in the U.S. healthcare system, supplying nearly 40 percent of the generic drugs imported into the country.
Mumbai (Maharashtra) [India], April 8: Lords Mark Industries Limited, a distinguished company known for its diverse portfolio, through its subsidiary Lord's Mark Global LLC, has made a strategic entry into the United States market by securing its first major order valued at approximately $1
Mumbai (Maharashtra) [India], April 7: Fabtech Technologies Cleanroom Ltd, a BSE-listed company specializing in cleanroom solutions, today announced that it has increased its ownership stake in Kelvin Air Conditioning & Ventilation Systems Pvt. Ltd. (Kelvin) from one-third to 51%. This a
India's leading pharmaceutical companies are expected to report strong sales growth of up to 16 per cent year-on-year (YoY) in the financial year 2024-25, according to a report by Centrum Institutional Research.
Mumbai (Maharashtra) [India], April 4: Dun & Bradstreet, a global leader in business decisioning data and analytics, has released its Economy Observer report for February 2025. Economy Observer is a monthly report sharing in-depth analysis of key macroeconomic developments in India and p
Congress leader and Leader of Opposition in Lok Sabha Rahul Gandhi said on Thursday that the United States' decision to impose reciprocal tariffs will "completely devastate our economy" with the auto industry, pharmaceuticals and agriculture among sectors expected to face the brunt.
Reacting to this, RK Aggarwal (National President, Bulk Drugs Manufacturers Association of India) said that it will have no impact on the pharma sector.
The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the pharmaceutical sector, has raised concerns about potential future trade restrictions on drug exports.
The Indian Pharmaceutical Alliance (IPA) on Thursday welcomed the exclusion of pharmaceuticals from US tariffs, with Secretary General Sudarshan Jain emphasising the deepening of India-US trade ties under the Mission 500 initiative, aiming to double bilateral trade to USD 500 billion.
Indian stock markets opened in selling pressure on Thursday, following a global decline triggered by U.S. President Donald Trump's latest tariff announcement. Investors reacted negatively, leading to a sharp drop in key indices at market opening.
The possible trade agreement between India and the United States could include key sectors such as agriculture, automobiles, and pharmaceuticals, says a report by Jefferies.